Coya Therapeutics, Inc. — Form 8-K
Filed September 15, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Coya Therapeutics filed an 8-K on 2026-09-15 under Item 8.01 (Other Events). The filing document itself contains no substantive disclosure text in the provided excerpt—only EDGAR metadata, company contact information (Houston, TX address), and XBRL technical files. The actual event details are not present in this extract.
Why this rating
Filing structure and metadata only; no business event disclosed. Cannot assess materiality without event description text.
Extracted items
See more from September 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.